15.24
price down icon2.74%   -0.43
after-market After Hours: 15.24
loading

Syndax Pharmaceuticals Inc Stock (SNDX) Latest News

pulisher
07:29 AM

Syndax Announces Participation in March Investor Conferences - The Manila Times

07:29 AM
pulisher
03:45 AM

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Up 6.7%Still a Buy? - MarketBeat

03:45 AM
pulisher
Feb 24, 2025

Syndax to Announce Fourth Quarter and Full Year 2024 - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025 - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Syndax Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

When Will Syndax Report Q4 Earnings? Key Date and Access Details Inside - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer - AOL

Feb 23, 2025
pulisher
Feb 23, 2025

Syndax Pharmaceuticals (SNDX) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Should investors be concerned about SNDX’s high price-to-sales ratio? - US Post News

Feb 21, 2025
pulisher
Feb 21, 2025

Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Here's Why We're Watching Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

When (SNDX) Moves Investors should Listen - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 18, 2025

Syndax Pharmaceuticals' SWOT analysis: stock poised for growth with FDA approvals - Investing.com

Feb 18, 2025
pulisher
Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Sells 4,618 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells 3,777 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Michael A. Metzger Sells 13,288 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 16, 2025
pulisher
Feb 15, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Don't Ignore The Insider Selling In Syndax Pharmaceuticals - Simply Wall St

Feb 15, 2025
pulisher
Feb 14, 2025

abrdn plc Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax pharmaceuticals CFO sells $58,558 in stock By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals CEO sells $206,017 in shares By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Feb 12, 2025
pulisher
Feb 11, 2025

Is Syndax Pharmaceuticals Inc (SNDX) positioned for future growth? - SETE News

Feb 11, 2025
pulisher
Feb 11, 2025

2 ‘Strong Buy’ Growth Stocks Poised For 141% To 193% Gains, According To Wall Street - Barchart

Feb 11, 2025
pulisher
Feb 11, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap UpShould You Buy? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewswire Inc.

Feb 10, 2025
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):